Company: TOMZ
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001654954-25-013088
Chunk: 40

Company: TOMI Environmental Solutions, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 40
---
.

On September 16, 2025, we announced the appointment of Francesco Fragasso to our Board of Directors.

On September 18, 2025, we announced FDA broadens permitted use of Hydrogen Peroxide; Ruling significantly expands potential application of SteraMist iHP.

On September 24, 2025, we announced a specialized service provider for Healthcare and Mold Remediation. This was the first of three major service provider companies we onboarded in Quarter 3, all of which have shown strong potential for expanded use of SteraMist iHP technology in their franchises. Our SteraMist Pro Certified program continues to be well received, supporting our efforts to finally build a robust network of certified partners.

Intellectual Property

Our intellectual property (IP) portfolio represents a key strategic asset, supporting our global leadership in disinfection and decontamination technologies. We currently hold or have pending over 25 utility or design patents worldwide, providing protection for both the methods and systems underlying our SteraMist® BIT™ platform. Our U.S. patents extend protection through 2038.

Recent additions to our portfolio include patents for backpack decontamination units, mobile carts, and applicator technology in the United States, along with new protection in Singapore, Korea, and other jurisdictions. We continue to pursue additional filings to broaden our coverage across Europe, China, and Australia.

We also hold more than 30 design patents for our decontamination devices; covering applicators, chambers, carts, and surface-mounted systems; across major global markets including the United States, China, Japan, Korea, and the United Kingdom.

 29Table of Contents

In addition, we maintain a robust trademark portfolio with over 200 trademarks registered or pending in multiple classes and countries. These marks cover the full range of our activities; from chemical formulations and sterilization equipment to services and training; reinforcing TOMI’s global brand presence.

Together, these patents and trademarks provide a comprehensive intellectual property framework that protects our core technology, supports market expansion, and strengthens our competitive position in critical sectors such as life sciences, aerospace, and biosecurity.

Financial Operations Overview

Our financial position as of September 30, 2025 and December 31, 2024, respectively, was as follows:

  September 30, 2025  December 31,     (Unaudited)  2024 Total shareholders' equity $2,206,000  $4,099,000 Cash and